Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanne Stevens

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
BMC Neuroscience|September 23, 2014
Differential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulatorsAnthony L Gotter, Susan L Garson, Joanne Stevens, et al.
Journal of Neurogenetics|April 9, 2011
Promotion of sleep by suvorexant-a novel dual orexin receptor antagonistChristopher J Winrow, Anthony L Gotter, Christopher D Cox, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2014
Synthesis and evaluation of carbon-linked analogs of dual orexin receptor antagonist filorexantScott D Kuduk, Jason W Skudlarek, Christina N Di Marco, et al.
Neuropharmacology|October 25, 2011
Pharmacological characterization of MK-6096 - a dual orexin receptor antagonist for insomniaChristopher J Winrow, Anthony L Gotter, Christopher D Cox, et al.
Bioorganic & Medicinal Chemistry Letters|May 19, 2015
Identification of MK-8133: An orexin-2 selective receptor antagonist with favorable development propertiesScott D Kuduk, Jason W Skudlarek, Christina N DiMarco, et al.
Brain Research|September 3, 2011
TASK-3 as a potential antidepressant targetAnthony L Gotter, Vincent P Santarelli, Scott M Doran, et al.
BMC Neuroscience|August 29, 2013
The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy thresholdAnthony L Gotter, Christopher J Winrow, Joseph Brunner, et al.
Scientific Reports|June 4, 2016
Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to ManAnthony L Gotter, Mark S Forman, Charles M Harrell, et al.
Science Translational Medicine|April 5, 2013
Orexin receptor antagonists differ from standard sleep drugs by promoting sleep at doses that do not disrupt cognitionJason M Uslaner, Spencer J Tye, Donnie M Eddins, et al.
Bioorganic & Medicinal Chemistry Letters|February 21, 2017
Investigation of orexin-2 selective receptor antagonists: Structural modifications resulting in dual orexin receptor antagonistsJason W Skudlarek, Christina N DiMarco, Kerim Babaoglu, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
BMC Neuroscience|September 23, 2014
Differential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulatorsAnthony L Gotter, Susan L Garson, Joanne Stevens, et al.
Journal of Neurogenetics|April 9, 2011
Promotion of sleep by suvorexant-a novel dual orexin receptor antagonistChristopher J Winrow, Anthony L Gotter, Christopher D Cox, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2014
Synthesis and evaluation of carbon-linked analogs of dual orexin receptor antagonist filorexantScott D Kuduk, Jason W Skudlarek, Christina N Di Marco, et al.
Neuropharmacology|October 25, 2011
Pharmacological characterization of MK-6096 - a dual orexin receptor antagonist for insomniaChristopher J Winrow, Anthony L Gotter, Christopher D Cox, et al.
Bioorganic & Medicinal Chemistry Letters|May 19, 2015
Identification of MK-8133: An orexin-2 selective receptor antagonist with favorable development propertiesScott D Kuduk, Jason W Skudlarek, Christina N DiMarco, et al.
Brain Research|September 3, 2011
TASK-3 as a potential antidepressant targetAnthony L Gotter, Vincent P Santarelli, Scott M Doran, et al.
BMC Neuroscience|August 29, 2013
The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy thresholdAnthony L Gotter, Christopher J Winrow, Joseph Brunner, et al.
Scientific Reports|June 4, 2016
Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to ManAnthony L Gotter, Mark S Forman, Charles M Harrell, et al.
Science Translational Medicine|April 5, 2013
Orexin receptor antagonists differ from standard sleep drugs by promoting sleep at doses that do not disrupt cognitionJason M Uslaner, Spencer J Tye, Donnie M Eddins, et al.
Bioorganic & Medicinal Chemistry Letters|February 21, 2017
Investigation of orexin-2 selective receptor antagonists: Structural modifications resulting in dual orexin receptor antagonistsJason W Skudlarek, Christina N DiMarco, Kerim Babaoglu, et al.
Pageof 4